The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene
Consulting or Advisory Role - Celgene
FIRST study: Updated overall survival (OS) in stem cell transplant (SCT)-ineligible newly diagnosed multiple myeloma (NDMM) patients (pts) treated with continuous lenalidomide plus low-dose dexamethasone (Rd) vs melphalan, prednisone, and thalidomide (MPT).
 
Thierry Facon
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene
 
Cyrille Hulin
Honoraria - Amgen; Celgene; Janssen
 
Meletios A. Dimopoulos
Honoraria - Celgene; Janssen; Onyx
Consulting or Advisory Role - Celgene; Janssen; Novartis; Onyx
Research Funding - Genesis Pharmaceuticals; Janssen
Travel, Accommodations, Expenses - Celgene; Janssen; Onyx
 
Andrew Belch
Consulting or Advisory Role - Amgen; Celgene
 
Donna Ellen Reece
Honoraria - Amgen; Celgene; Janssen; Lundbeck; Novartis
Consulting or Advisory Role - Celgene; Janssen; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Janssen; Merck; Millennium; Novartis; Novartis; Otsuka
 
John V. Catalano
Honoraria - Celgene
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche Pharma AG
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Celgene; Novartis; Roche Pharma AG
 
Antonio Pinto
Honoraria - Celgene; Mundipharma; Roche Pharma AG; Takeda; Teva
 
Heinz Ludwig
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Onyx
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Onyx
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Onyx
Research Funding - Takeda (Inst)
 
Nizar J. Bahlis
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Celgene; Johnson & Johnson
Speakers' Bureau - Celgene; Johnson & Johnson
Research Funding - Celgene; Johnson & Johnson
 
Michele Cavo
No Relationships to Disclose
 
Philippe Moreau
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene
 
Lugui Qiu
Honoraria - Celgene; Johnson & Johnson
 
Richard LeBlanc
Honoraria - Celgene
Consulting or Advisory Role - Celgene
 
Rik Schots
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
S. Vincent Rajkumar
No Relationships to Disclose
 
Jennifer Marek
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Guang Chen
Employment - Celgene
 
Annette L. Ervin-Haynes
Employment - Celgene